Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Tiered cost model for access to a computer network
Method and apparatus for allocating erasure coded data to disk storage
Imaging lens
Semiconductor device and method for manufacturing same
Remote ignition system for a vehicle and method for securing a remote ignition function
Method and apparatus for increasing query traffic to a web site
Differentiated PSIP table update interval technology
  Randomly Featured Patents
Massage device
Portable display equipment
Fuel tank ventilating system
Reversible bra
Printed circuit board
Cooler for golf carts
Method of preparing chalcogenides of group VIII by low temperature precipitation from monaqueous solution, the products produced by said method and their use as catalysts
System for monitoring vehicles having a start and a stop pair of beams
Turbidimeter improvements
Efficient detection of multiple assertions in a bus